JPRN-UMIN000002899
Recruiting
未知
A clinical study of the living-unrelated renal transplantation with restored kidneys (interventional trial) - A clinical study of the living renal transplantation with restored kidneys between third parties
Tokushukai Medical Group0 sites20 target enrollmentDecember 15, 2009
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- iving renal transplantations between third parties with restored donor kidneys in order to acquire necessary clinical data for expanding renal donor pool and availability in Japan as well as to provide useful medical care for patients who are on dialysis urging for renal transplant and waiting for many years.
- Sponsor
- Tokushukai Medical Group
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •For Recipient: 1\) Patients having infectious disease, hemorrhagic ulcer, or malignant cancer 2\) Patients having serious vascular lesions (eg. Arteriosclerosis, thromboembolic disease) and currently on treatment 3\) Patients not approved by the Institutional Ethics Committee For Donor: 1\) Patients positive for serious infectious disease (eg. HIV, HBV, or HCV) 2\) Patients diagnosed as having malignant lymphoma or sarcoma 3\) Patients on chemotherapy or radiation therapy for renal cancer prior to the nephrectomy 4\) Patients not approved by the Institutional Ethics Committee (\*) Other exclusion criteria defined in the protocol for both recipient and donor may apply.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A clinical study of living-related renal transplantation with restored kidneys (interventional trial)iving renal transplantations between family members with restored donor kidneys in order to acquire necessary clinical data for potential enrichment of the renal donor pool in Japan as well as to develop useful medical care for patients who are on dialysis for many years due to the renal failure.JPRN-UMIN000003257Tokushukai Medical Group5
Not yet recruiting
Not Applicable
A study of kidney Problems with covid 19 in admitted patients at a teritiary care hospital.Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 3: B338- Other specified viral diseasesCTRI/2020/12/029581nil
Recruiting
Not Applicable
A clinical study to evaluate the effect of renal impairment of the pharmacokinetics of oral administration of Factive Tab. 320mgDiseases of the genitourinary systemKCT0006146Chonnam National University Hospital28
Active, not recruiting
Phase 1
Evaluation of the impact of renal function on the pharmacokinetics of hydroxyurea (Siklos®) in patients with sickle cell disease with normal renal function, with hyperfiltration, or with renal failure. DARH studySiklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in adults, adolescents and children older than 2 years suffering from symptomatic sickle cell syndrome.MedDRA version: 17.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004851Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2014-005033-31-FRAddmedica S.A.S
Completed
Phase 3
Renal complications of Amikacin in patients with neonatal sepsisIRCT20201212049686N1Tehran University of Medical Sciences90